Grant of share options and restricted share units
Filed with HKEX · Stock code 2228 · · 6 pages · English
XtalPi Holdings Limited on 6ix
Earlier from XtalPi
- XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
- Voluntary announcement plan to increase shareholding in the company by the chairman of the board
- Voluntary announcement strategic drug discovery collaboration between xtalpi subsidiary LCC technologies and stanford university
- XtalPi Holdings Limited to Announce 2026 Interim Results on August 19, 2026
- XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
Later from XtalPi
- XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
- Next Day Disclosure Return
- XtalPi and Fangda Carbon Deploy Predictive AI to Optimize Cost and Material Efficiency in Graphite Electrode Manufacturing
- XtalPi Advances Hair Loss Drug Program into IND-Enabling Studies
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow XtalPi into a list and get an email when it puts out news.
Follow XtalPi